Guoyuan International: Target price of HK$28 for Kang Feng Biotech (06922) “buy” rating
Kang Feng Bio-B (6922.HK): Outstanding clinical efficacy of leading cryointerventional devices is about to usher in high growth
Kangfeng Biotech B (6922.HK): A growing pioneer in interventional cryotherapy in China
No Data